Lancet Capital

Description

Lancet Capital actively seeks to bring value to portfolio companies throughout the venture-building process.

Lancet Capital , the first SBIC affiliated with an academic medical center, was founded in 1998 by William Golden and George Sing to create value for investors and founders/management of early stage biomedical portfolio companies.

Stemnion , founded and seeded by Lancet Capital, is a privately held regenerative medicine company focused on the research, development and clinical use of its proprietary technology platform, derived from specialized human cells. This platform provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies for which there is no satisfactory treatment.

Fact sheet

Company contacts

Companies nearby